Clinical trials: Dysexecutive Syndrome, active
Dysexecutive Syndrome, Post-Acute Sequelae of COVID-19
Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)
The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcranial direct current…
- Trial name
- NCT05092516
- Testing
- Active tDCS
- Where
- United States
- Volunteers
- 31 people
- Sponsor
- Massachusetts General Hospital
Dysexecutive Syndrome
Study for the Quantification in Ecological Conditions of Sensorimotor and Dysexecutive Disorders in Cerebral Palsy Patients
Executive functions are defined as the mental functions necessary for an individual to adapt to a complex or new environment that requires freedom from automatic and routine behavior.
- Trial name
- SDS2 (NCT05017051)
- Testing
- Chocolate cake, Lego model, Measurement of sensorimotor abilities
- Where
- France
- Volunteers
- 442 people, healthy volunteers welcome
- Sponsor
- Direction Centrale du Service de Santé des Armées